Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18555657 | 0.97 | TDP1 (0.45) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| SCHEMBL18555820 | 0.97 | TDP1 (0.45) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| SCHEMBL27760960 | 0.97 | TDP1 (0.45) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| Water SCHEMBL3307446 | 0.97 | TDP1 (0.41) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| SCHEMBL3313068 | 0.97 | TDP1 (0.45) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| SCHEMBL2000597 | 0.92 | — | — | |
| Water SCHEMBL3302088 | 0.89 | PTGS1 (0.36) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| Bromide SCHEMBL21248489 | 0.89 | PTGS1 (0.36) | TDP1HRH4HRH3POLBSMN1; SMN2 | |
| SCHEMBL22932144 | 0.87 | CYP4F2 (0.42) | TDP1HRH4HRH3POLBALDH1A1 | |
| Formic Acid SCHEMBL27760962 | 0.87 | TDP1 (0.43) | TDP1HRH4HRH3POLBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118059941-A | Coordination metal catalyst, preparation method and application thereof, hindered amine and preparation method thereof | 中国石油天然气股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118022517-A | Desulfurizing agent for absorbing hydrogen sulfide and organic sulfur under normal pressure and preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-107073386-B | Removal of carbon dioxide from fluid streams using tert-butylamine and an activator | 巴斯夫欧洲公司 | 2020-07-03 | — | — | CN | claimed |
| US-10279309-B2 | Removal of carbon dioxide from a fluid flow | BASF SE (DE) | 2019-05-07 | — | — | US | claimed |
| EP-3185990-B1 | REMOVAL OF CARBON DIOXIDE FROM A FLUID FLOW, USING A TERT BUTYLAMINE AND AN ACTIVATOR | BASF SE (DE) | 2018-10-17 | — | — | EP | claimed |
| US-20170282116-A1 | REMOVAL OF CARBON DIOXIDE FROM A FLUID FLOW | BASF SE (DE) | 2017-10-05 | — | — | US | claimed |
| CN-107073386-A | Carbon dioxide is removed from fluid stream using tert-butylamine and activator | 巴斯夫欧洲公司 | 2017-08-18 | — | — | CN | claimed |
| EP-3185990-A2 | REMOVAL OF CARBON DIOXIDE FROM A FLUID FLOW, USING A TERT BUTYLAMINE AND AN ACTIVATOR | BASF SE (DE) | 2017-07-05 | — | — | EP | claimed |
| CN-118059941-A | Coordination metal catalyst, preparation method and application thereof, hindered amine and preparation method thereof | 中国石油天然气股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118022517-A | Desulfurizing agent for absorbing hydrogen sulfide and organic sulfur under normal pressure and preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117902991-A | Sterically hindered amine, desulfurization solvent and preparation method | 中国石油天然气股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-11834454-B2 | Alkynylphenylbenzamide compounds and applications thereof | SHENZHEN NEWDEL BIOTECH CO., LTD. (CN) | 2023-12-05 | — | — | US | disclosed |
| US-11834454-B2 | Alkynylphenylbenzamide compounds and applications thereof | SHENZHEN NEWDEL BIOTECH CO., LTD. (CN) | 2023-12-05 | — | — | US | disclosed |
| US-11773065-B2 | Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-10-03 | — | — | US | disclosed |
| WO-1997014710-A1 | PREPARATION OF PHOSPHOROTHIOATE OLIGOMERS | MCGILL UNIVERSITY (US) | 1997-04-24 | — | — | WO | disclosed |
| US-5622947-A | VASODILATORS, HYPOTENSIVE AGENTS, DIURETICS, PLATELET AGGLUTINATION INHIBITORS; ALSO USED TO PREVENT PREMATURE BIRTH, TREAT DYSMENORRHEA | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| EP-0765314-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995034540-A1 | BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-12-21 | — | — | WO | disclosed |
| EP-0620003-A1 | VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| US-4788277-A | OXIDATIVE COUPLING, CATALYST CONTAINING COPPER, DIAMINE, HALOGEN | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834454-B2 | Alkynylphenylbenzamide compounds and applications thereof | ALK, NTRK1, ERBB2 | TDP1 2371/4885HRH4 2239/4885HRH3 2260/4885 |
| US-11773065-B2 | Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists | GPR52, GPR68, GPR65 | TDP1 4390/4885HRH4 151/4885HRH3 300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.